USANA Health Sciences, Inc.

Equities

USNA

US90328M1071

Food Processing

Market Closed - Nyse 04:00:02 2024-04-17 pm EDT 5-day change 1st Jan Change
43.01 USD -0.42% Intraday chart for USANA Health Sciences, Inc. -5.43% -19.76%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Usana Health Sciences Insider Sold Shares Worth $539,539, According to a Recent SEC Filing MT
Usana Health Sciences Insider Sold Shares Worth $257,022, According to a Recent SEC Filing MT
WeightWatchers shares drop as Oprah Winfrey decides to exit board RE
Transcript : USANA Health Sciences, Inc., Q4 2023 Earnings Call, Feb 07, 2024
USANA Health Sciences Seeks Acquisition Opportunities CI
(USNA) USANA HEALTH SCIENCES Forecasts Q1 Revenue Range $850M - $920M MT
Earnings Flash (USNA) USANA HEALTH SCIENCES Posts Q4 EPS $0.87, vs. Street Est of $0.52 MT
(USNA) USANA HEALTH SCIENCES Forecasts Fiscal Year 2024 EPS Range $2.40 - $3 MT
(USNA) USANA HEALTH SCIENCES Forecasts Fiscal Year 2024 Revenue Range $850M - $920M MT
Tranche Update on USANA Health Sciences, Inc.'s Equity Buyback Plan announced on December 8, 2015. CI
USANA Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 30, 2023 CI
USANA Health Sciences, Inc. Provides Earnings Guidance for the Fiscal Year 2024 CI
USANA Health Sciences, Inc. Reports Earnings Results for the Fourth Quarter Ended December 30, 2023 CI
USANA Health Sciences, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
DA Davidson Cuts USANA Health Sciences' Price Target to $53 From $62, Keeps Neutral Rating MT
Transcript : USANA Health Sciences, Inc., Q3 2023 Earnings Call, Oct 25, 2023
USANA Health Sciences' Q3 Earnings, Sales Decline; Annual Guidance Revised MT
(USNA) USANA HEALTH SCIENCES Forecasts Fiscal Year 2023 EPS Range $2.80 - $3.05 MT
Earnings Flash (USNA) USANA HEALTH SCIENCES Posts Q3 Revenue $213.4M, vs. Street Est of $220.4M MT
Tranche Update on USANA Health Sciences, Inc.'s Equity Buyback Plan announced on December 8, 2015. CI
USANA Health Sciences, Inc. Revises Earnings Guidance for the Year 2023 CI
USANA Health Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Insider Sell: Usana Health Sciences MT
Insider Sell: Usana Health Sciences MT
Transcript : USANA Health Sciences, Inc., Q2 2023 Earnings Call, Jul 26, 2023
Chart USANA Health Sciences, Inc.
More charts
USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Company’s product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
43.01 USD
Average target price
56.5 USD
Spread / Average Target
+31.36%
Consensus
  1. Stock Market
  2. Equities
  3. USNA Stock
  4. News USANA Health Sciences, Inc.
  5. Insider Trends: 90-Day Insider Buying Trend Reduced with Disposition of USANA Health Sciences Shares